Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid and Sucralfate in Gastrointestinal Bleeding
NCT06421389Completed
- Sponsor
- National Cheng Kung University Hospital
- Start
- Aug 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tranexamic acid and sucralfate in gastrointestinal bleeding (2 arms), sponsored by National Cheng Kung University Hospital. Primary endpoint: Recurrent rate of GI bleeding at 28 days. Started Aug 2024; status: completed.
02
Drugs
tranexamic acidsucralfate
03
Conditions
gastrointestinal bleeding
Beyond the preview
Go deeper on NCT06421389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06421389.